000300245 001__ 300245
000300245 005__ 20250821121029.0
000300245 0247_ $$2pmid$$apmid:40181766
000300245 0247_ $$2ISSN$$a0094-2405
000300245 0247_ $$2ISSN$$a1522-8541
000300245 0247_ $$2ISSN$$a2473-4209
000300245 0247_ $$2doi$$a10.1002/mp.17797
000300245 037__ $$aDKFZ-2025-00706
000300245 041__ $$aEnglish
000300245 082__ $$a610
000300245 1001_ $$00000-0001-7882-9060$$aBolzonella, Matteo$$b0
000300245 245__ $$aOut-of-field neutron radiation from clinical proton, helium, carbon, and oxygen ion beams.
000300245 260__ $$aHoboken, NJ$$bWiley$$c2025
000300245 3367_ $$2DRIVER$$aarticle
000300245 3367_ $$2DataCite$$aOutput Types/Journal article
000300245 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1749558518_8467
000300245 3367_ $$2BibTeX$$aARTICLE
000300245 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000300245 3367_ $$00$$2EndNote$$aJournal Article
000300245 500__ $$a#LA:E040# / 2025 Jun;52(6):4924-4940
000300245 520__ $$aIn hadron therapy, out-of-field doses, which may in the long-term cause secondary cancers, are mostly due to neutrons. Very recently, 4He and 16O beams have been added to protons and 12C ions for clinical therapy.The focus of this article is to compare secondary neutron doses produced by clinical protons, 4He, 12C, and 16O ion beams.Ambient dose equivalent, H*(10), measurements were performed, with five types of rem counters, of the neutron field produced by the four primary ions impinging on a water phantom. This experiment was performed at the Heidelberg Ion Beam Therapy Center (HIT) in the framework of the activities of the European Radiation Dosimetry Group (EURADOS). The experimental data are normalized to both unit primary particle and target dose, and are further compared to Monte Carlo (MC) simulations performed with the FLUKA and MCNP codes.The intensity of the neutron field increases with ion mass, and the trend is more significant in the forward direction. The minimum H*(10) for all ions, 5µSv/Gy to 10µSv/Gy, was measured in the transverse and backward directions, whereas the maximum measured value was about 1.3 mSv/Gy for primary 16O ions in the forward direction. Additional MC simulations are presented for a more detailed analysis of the rem counters' response in the presence of heavy charged fragments. In the downstream direction, for 12C and 16O ions, approximately only 30% of the instruments' counts are due to neutrons.The four extended-range instruments provide reliable and consistent results, whereas the conventional rem counter underestimates H*(10) in a neutron field with a large high-energy component. FLUKA and MCNP provide consistent predictions, within a factor of 1.6 for the downstream position and lower differences in the other cases, and are in agreement with the experimental data. It was found that under certain conditions neutrons do not represent the only secondary radiation field to be monitored; the presence of charged particles affects the performance of moderator-type neutron detectors.
000300245 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000300245 588__ $$aDataset connected to DataCite, PubMed, , Journals: inrepo02.dkfz.de
000300245 7001_ $$00000-0002-6860-7859$$aCaresana, Marco$$b1
000300245 7001_ $$00000-0001-9432-1734$$aCirillo, Andrea$$b2
000300245 7001_ $$00000-0003-2020-8127$$aMartí-Climent, Josep M$$b3
000300245 7001_ $$00009-0008-4254-9305$$aMartínez-Francés, Evangelina$$b4
000300245 7001_ $$0P:(DE-He78)cb4929efca771624c62eda90086b144d$$aMooshammer, Christina$$b5$$udkfz
000300245 7001_ $$0P:(DE-He78)f726c09d369bb3767687f686aa6694fb$$aSchmidt, Stefan$$b6$$udkfz
000300245 7001_ $$00000-0002-4695-0816$$aBrons, Stephan$$b7
000300245 7001_ $$00000-0001-8851-0950$$aSilari, Marco$$b8
000300245 7001_ $$0P:(DE-He78)5d3fd2061719ec17ba3c894c81dbde89$$aStengl, Christina$$b9$$udkfz
000300245 7001_ $$00000-0002-6333-3350$$aStolarczyk, Liliana$$b10
000300245 7001_ $$0P:(DE-He78)d028533bf57b4053bc9b94b70daab443$$aVedelago, Jose Alberto$$b11$$eLast author$$udkfz
000300245 773__ $$0PERI:(DE-600)1466421-5$$aDOI:10.1002/mp.17797$$n6$$p4924-4940$$tMedical physics$$v52$$x0094-2405$$y2025
000300245 909CO $$ooai:inrepo02.dkfz.de:300245$$pVDB
000300245 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-13$$wger
000300245 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMED PHYS : 2022$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-13
000300245 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-13
000300245 9141_ $$y2025
000300245 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cb4929efca771624c62eda90086b144d$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000300245 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f726c09d369bb3767687f686aa6694fb$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000300245 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5d3fd2061719ec17ba3c894c81dbde89$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000300245 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d028533bf57b4053bc9b94b70daab443$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000300245 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000300245 9202_ $$0I:(DE-He78)E040-20160331$$kE040$$lE040 Med. Physik in der Strahlentherapie$$x0
000300245 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lE040 Med. Physik in der Strahlentherapie$$x0
000300245 980__ $$ajournal
000300245 980__ $$aVDB
000300245 980__ $$aI:(DE-He78)E040-20160331
000300245 980__ $$aUNRESTRICTED